Guidance and quality standards awaiting development | Guidance

Showing 81 to 90 of 410

Guidance and quality standards awaiting development
Title	Type
Deucravacitinib for treating active Sjogren's disease [ID6715]	Technology appraisal guidance
Deucravacitinib for treating systemic lupus erythematosus [TSID12405]	Technology appraisal guidance
Dexamethasone intracanalicular insert for treating inflammation and pain after cataract surgery [ID1154]	Technology appraisal guidance
Diabetic foot problems: prevention and management - topical wound oxygen therapy for diabetic foot ulcers	NICE guideline
Divarasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer	Technology appraisal guidance
Diverticular disease	Quality standard
Donanemab for reducing the risk of mild cognitive impairment in preclinical Alzheimer's disease [ID6675]	Technology appraisal guidance
Doravirine-islatravir for previously untreated HIV-1 infection	Technology appraisal guidance
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy	Technology appraisal guidance
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment	Technology appraisal guidance